Your browser does not support JavaScript capabilities, which maybe required to display this page properly.


PDF FormatRequires Adobe Acrobat Reader

Table 5.12d

Adjusted Patient Survival, Living Donor Kidney Transplants

Survival at 3 Months, 1 Year, 5 Years, and 10 Years

  3 Months 1 Year 5 Years 10 Years
(Tx 2005 - 2006) (Tx 2005 - 2006) (Tx 2001 - 2006) (Tx 1996 - 2006)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 11,604 99.5% 0.1% 11,604 98.5% 0.1% 34,235 91.5% 0.2% 54,408 77.1% 0.4%
Primary Diagnosis Glomerular Diseases 3,311 99.7% 0.1% 3,311 99.0% 0.2% 10,032 94.1% 0.3% 16,615 84.6% 0.5%
Diabetes 2,497 99.2% 0.2% 2,497 97.6% 0.3% 7,463 85.7% 0.6% 11,711 61.1% 0.9%
Hypertensive Nephrosclerosis 1,822 99.1% 0.2% 1,822 98.0% 0.3% 4,701 89.7% 0.6% 6,985 72.2% 1.1%
Polycystic Kidneys 1,304 99.7% 0.1% 1,304 99.2% 0.2% 3,641 95.6% 0.5% 5,269 86.8% 1.0%
Tubular and Interstitial Diseases 694 99.7% 0.2% 694 98.5% 0.4% 2,212 89.4% 0.9% 3,805 77.9% 1.2%
Renovascular & Other Vascular Diseases 296 99.7% 0.3% 296 98.6% 0.6% 1,207 92.0% 0.9% 1,982 69.8% 2.1%
Congenital, Rare Familial, & Metabolic Disorders 429 98.8% 0.6% 429 98.3% 0.8% 1,387 93.7% 1.1% 2,271 83.5% 1.8%
Neoplasms 47 98.3% 1.6% 47 98.3% 1.6% 159 88.2% 3.2% 240 72.8% 5.4%
Other 1,181 99.3% 0.2% 1,181 98.4% 0.4% 3,383 92.1% 0.6% 5,461 79.0% 1.1%
Unknown 23 + + 23 + + 50 90.4% 6.5% 69 65.0% 12.4%


Source: OPTN/SRTR Data as of May 1, 2008.

(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Patient survival follows patients from first transplant of this type until death. Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on kidney and kidney-pancreas transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.



PDF FormatRequires Adobe Acrobat Reader